Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France.

Cancer Commun (Lond) · 2019 · PMC6686550 · PMID 31395093

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, the authors also demonstrated that HIPEC helps to kill the residual cancer present, delaying or abrogating intraperitoneal recurrence; as in their study, CRS-HIPEC was statistically associated with major survival benefits in comparison with CRS alone and also showed a trend towards more isolated extraperitoneal recurrences.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.